| About the Society|
The Asian Journal of Pediatric Nephrology (AJPN) is the official journal of the Asian Pediatric Nephrology Association (AsPNA). The AsPNA aims to promote the science and art of Pediatric Nephrology in Asia with highest level of professional skills and ethics in clinical practice.
- to promote the science and art of Pediatric Nephrology in Asia
- to maintain the highest level of professional skills and ethics in the practice of the subspecialty
- to foster regional camaraderie and cooperation among member nations
- to represent AsPNA in IPNA and other international/regional nephrology endeavors.
Dr. Tadasu Sakai broached the idea of establishing a Working Group for Pediatric Nephrology in Asia in Philadelphia in 1980. After 6 years of further talks, core founding members were identified: Drs. Tadasu Sakai and Fumio Yamashita (Japan), KW Ko (Korea), CH Chen (Taiwan), RN Srivastava (India), WQ Kang (China), IGN Wila Wirya (Indonesia), Voranunt Suphipant (Thailand), Indon Lajin (Malaysia) and Carmelo Alfiler (Philippines).
The historic first symposium on “epidemiology and treatment of renal disease in Asian countries” was held in Tokyo on June 25, 1988. It would be followed by highly successful congresses in Nagoya (1989), Seoul (1991), Taipei (1993), New Delhi (1994), Manila (1996), Singapore (2000), and Jeju (2002).
In 1989, the group became known as the Asian Society of Pediatric Nephrology (ASPN), still with Dr. Sakai as leader.
Information about the Asian Pediatric Nephrology Association is available at www.aspna-online.org
About the Journal
The Asian Journal of Pediatric Nephrology (AJPN), the official journal of the Asian Pediatric Nephrology Association (AsPNA) was launched to enhance camaraderie and cooperation among specialists in various member nations, and endeavors to represent Asia in the International Pediatric Nephrology Association. AJPN journal provides a platform for reporting clinical and research findings from Asian countries, which are often underrepresented in international reports. Through educational reviews and regionally relevant guidelines, the Journal shall provide recommendations for practices that are feasible for implementation across Asia. Initially proposed as an e-journal with 2-3 issues per year, we aim for a print version in few years.
The AJPN invites its readers to submit clinical and research findings for dissemination among peers in the specialty. Reporting your findings provides pediatric nephrologists, across the world, an opportunity to learn from your experience. You may submit your findings as original article, systematic review or meta-analysis, case report or letter to the Editor. All manuscripts shall undergo a formal peer-review process. More details and guidance on the submission process are available at Instructions for Authors
To learn more about publication policy and the publishers of the Journal, please visit About MedKnow and WolterKluwers
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, Netherlands ISSN centre, ProQuest, TDNet, Wanfang Data
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
- "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
- The Editorial Board has full and final approval over the content of all advertisements.
- Advertisers will never be shown any manuscripts or other content prior to publication.
The journal will cover technical and clinical studies related to health, ethical and social issues in the field of epidemiology of renal disorders, clinical nephrology, hypertension and vasculitis, nephrourology, applied renal physiology, pharmacology, immunology and genetics, pediatric dialysis and transplantation, public health, and protocols in pediatric nephrology. Articles of clinical interest and those having implications in clinical practice will be preferred.